A Unique Molecular Profile for Lung Cancer
The expression pattern of certain microRNAs, or miRNAs, may predict tumor aggressiveness in some patients with lung cancer.
|
Researchers Block Cancer-Promoting Signals in Most Common Form of Lung Cancer
Scientists don't know yet whether this approach will lead to improved therapy for lung cancer patients.
|
Tumor Size Related To Lung Cancer Spread
Smaller tumors in the lungs appear to be less likely to have spread than larger tumors among patients with asymptomatic lung cancer.
|
Lung Cancer Screening Encouraged for Smokers
To detect invasive lung cancer in its early stages, researchers urge current and former smokers who have a strong family history of the disease to take a lung cancer test.
|
New Antibody Profiling Technique to Test for Lung Cancer
Only 25 percent of new lung cancer cases are diagnosed at an early stage, when curative surgery is possible.
|
Chest X-Rays Can Detect Early Lung Cancer But...
Screening for lung cancer with chest X rays can detect early lung cancer but also can produce many false positive test results.
|
Learn the Signs and Symptoms of Lung Cancer
Symptoms of lung cancer include persistent cough or coughing blood, recurring pneumonia, unexplained weight loss, and fatigue.
|
Race Can Affect Decision About Lung Cancer Treatment
Race may play a role in whether a patient accepts surgical treatment for lung cancer.
|
Restoring Silenced Suppressor Gene Kills Lung Cancer Cells
Restoring a gene often silenced in lung cancer causes the cells to self destruct possibly leading to a new strategy for treating lung cancer.
|
Experimental Compound Reduces Lung Damage After Radiation
A single dose of an experimental compound called 1D11 successfully prevented severe lung damage from occurring in mice that underwent radiation therapy to treat lung cancers.
|
Gene Therapy May Protect Normal Tissues During Radiation Retreatment for Lung Cancer
A major challenge in treating lung cancers with radiation is the toxicity of radiation to healthy tissue.
|
Vitamin D Improves Survival with Non Small Cell Lung Cancer
Standard treatment for non small cell lung cancer largely depends upon the stage of spread of the lung cancer and may include surgery.
|
Eating Foods With "Weak Estrogens" May Help Reduce Lung Cancer Risk
If estrogen drugs could protect against lung cancer, the researchers wondered if the same is true of foods that have naturally occurring low levels of estrogens.
|
Lung Cancer Can Strike Anyone, But Smokers Are At Greatest Risk
Lung cancer is typically most treatable when caught early, but detecting lung cancer in its earliest stages is difficult.
|
Two Designer Drugs Hit Same Lung Cancer Target, But Only One Is Effective
Although both drugs killed cells containing a normal but overactive EGFR (epidermal growth factor receptor) molecule, only gefitinib (Iressa) killed lung cancer cells containing a mutated EGFR molecule.
|
Study Finds Tarceva Benefits Older Lung Cancer Patients
It may be beneficial to use erlotinib to initially treat patients with advanced lung cancer, rather than use conventional chemotherapy regimens.
|
Higher Consumption of Some Soy Products, Grains, Vegetables and Fruits Associated with Reduced Risk of Lung Cancer
Reduction in lung cancer risk tended to increase with increasing phytoestrogen intake.
|
Chemotherapy and Radiation Together May Be Better for Patients with Locally Advanced Lung Cancer
A new study led by lung cancer specialists adds to evidence that giving patients both chemotherapy and radiation in the beginning of treatment may help patients live longer.
|
For Individuals With Family History Of Lung Cancer, Risk Greater For Blacks Than Whites
First degree relatives of black individuals with early onset lung cancer have twice the risk of lung cancer than first degree relatives of white individuals with early onset lung cancer.
|
Diagnostic Strategy May Help Determine Stage Of Lung Cancer More Accurately
A preoperative testing strategy combining two procedures may help improve the accuracy of determining the stage of lung cancer.
|
Integrated Implementation Plan to Fight Lung Cancer
The primary cause of lung cancer is tobacco smoke. If we are going to be serious about improving health and preventing lung cancer, we must continue to drive down tobacco use.
|
Building a Better Mouse Model of Lung Cancer
Scientists have identified some of the very earliest genetic changes involved in the development of lung cancer.
|
Cancer Researchers Find Potential Target for Celebrex in Lung Cancer
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer.
|
Two Ultrasound Procedures Combined Are Superior To Bronchoscopic Biopsy To Detect Lung Cancer Spread
About half of all lung cancers are caught after they have spread to nearby lymph nodes.
|
Researchers Discover Tumor Product That Suppresses Immune Function in Lung Cancer
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy.
|
Minimally Invasive Surgery Treats Early Lung Cancers
UM doctors use new surgical method for lung cancer treatment that has patients out of the hospital and is less painful than traditional lung cancer surgery.
|
Mouse Model Paves Way for Lung Cancer Studies
There has been such a lack of good experimental models for studying tobacco induced lung cancers.
|
Concurrent Radiation, Chemo, Followed by Surgery Lengthens Lung Cancer Patients' Survival
Patients whose lung cancer has spread to the lymph nodes have a better chance of long term survival if they receive combined modality therapy.
|
Novel Lung Cancer Treatment May Change the Standard of Care
The addition of the monoclonal antibody Bevacizumab (Avastin) to the standard treatment for advanced, non squamous non small cell lung cancer produced improved survival rates.
|
New Devices Help Surgeons 'Clear The Air' of Lung tumors
Surgeons can see lung disease and early signs of cancer that would otherwise be undetectable with a CAT scan, blood test or white light bronchoscopy.
|
New Class of Drugs May Treat Lung Tumors Resistant to Iressa and Tarceva
Study reveals complex mechanism underlying resistance to targeted lung cancer drugs.
|
New High-Tech Approach Identifies Two Proteins Involved in Lung Cancer
Finding a new approach that can pinpoint which proteins contribute to malignancy is critical because current approaches we use to diagnose and treat lung cancer have had no significant impact on lung cancer mortality.
|
Clinical Trial of Gefitinib for Advanced Lung Cancer Closes Early
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa TM) vs. placebo following chemotherapy and radiation for patients with non small cell lung cancer.
|
New Blood Test Could Detect Lung Cancer In Its Earliest Stages
Scientists are developing a non invasive test that could detect lung cancer in its earliest stages, while it is still treatable.
|
Bevacizumab Combined with Chemotherapy Prolongs Survival for Some Patients with Advanced Lung Cancer
Results from a clinical trial for patients with previously untreated advanced non squamous, non small cell lung cancer show that those patients who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.
|
Researchers Discover Why Tumor Resists Therapy
Lung Cancer Patients May Benefit From Study, which helps to explain why non small cell lung cancer (NSCLC) tumors become resistant to the cancer therapy gefitinib.
|
